Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera dose-response in anemic multiple myeloma patients
NCT00360347Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2001
- Primary completion
- Apr 2003
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of methoxy polyethylene glycol-epoetin beta in anemia, sponsored by Roche. Started Nov 2001; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00360347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360347.